| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |